Who owns BIO-KEY INTL INC?
- CUSIP Number: 09060c507
Tip: Access positions for across all investors
Analyze quarterly positions in Bio-key Intl with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Bio-key Intl stock
Who bought or sold BIO-KEY INTL INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 295k | $157k | 504% | Mar 2026 |
|
| Citigroup | 50k | $27k | 100% | Mar 2026 |
|
| Vanguard Capital Management | 35k | $19k | 100% | Mar 2026 |
|
| Virtu Financial | 21k | $11k | 100% | Mar 2026 |
|
| Susquehanna International | 17k | $9.1k | 100% | Mar 2026 |
|
| UBS Group | 5.6k | $2.9k | -64% | Mar 2026 |
|
| Morgan Stanley | 2.0k | $1.1k | 100% | Mar 2026 |
|
| Tower Research Capital | 1.8k | $928.914700 | 0% | Mar 2026 |
|
| SBI Securities | 300.00 | $159.000000 | 0% | Mar 2026 |
|
Who sold out of Bio-key Intl?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 32k | $17k |
| Jane Street | Dec 2025 | 25k | $14k |
| Flow Traders US | Dec 2025 | 11k | $6.0k |
| Signature Resources Capital Management | Dec 2025 | 1.0k | $539.000000 |